PolyPid (PYPD) Prepaid Assets (2020 - 2026)
PolyPid (PYPD) posted Prepaid Assets of $351000.0 for Q1 2026, down 64.72% sequentially from $995000.0 in Q4 2025, and down 38.2% YoY from $568000.0 in Q1 2025.
PolyPid (PYPD) Prepaid Assets (2020 - 2026) Analysis & Trends
PolyPid has reported Prepaid Assets for 7 years, with the latest figure at $351000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 38.2% year-over-year to $351000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $351000.0 (down 38.2% YoY) and the FY2025 annual result came in at $995000.0, up 30.24% from the prior year.
- Prepaid Assets slipped to $351000.0 in Q1 2026 per PYPD's latest filing, from $995000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.5 million in Q1 2022 and troughed at $144000.0 in Q2 2023.
- A 5-year average of $657352.9 and a median of $568000.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets plunged 78.21% in 2023, then surged 86.11% in 2024.
- Over 5 years, Prepaid Assets stood at $1.1 million in 2022, then sank by 57.94% to $458000.0 in 2023, then jumped by 66.81% to $764000.0 in 2024, then soared by 30.24% to $995000.0 in 2025, then tumbled by 64.72% to $351000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $351000.0, $995000.0, and $609000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PolyPid | 113.86 Mn | 107.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 757,000.00 |
| Mar 31, 2026 | 351,000.00 |
| Dec 31, 2025 | 995,000.00 |
| Sep 30, 2025 | 609,000.00 |
| Jun 30, 2025 | 351,000.00 |
| Mar 31, 2025 | 568,000.00 |
| Dec 31, 2024 | 764,000.00 |
| Sep 30, 2024 | 750,000.00 |
| Jun 30, 2024 | 268,000.00 |
| Mar 31, 2024 | 471,000.00 |
| Dec 31, 2023 | 458,000.00 |
| Sep 30, 2023 | 473,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 448,000.00 |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 661,000.00 |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 2.21 Mn |
| Sep 30, 2021 | 3.34 Mn |